BACKGROUND: Patients with chromosome 22q11.2 deletion syndrome (22q11DS) are at a seven fold increased risk of developing seizures. However, only a fraction of these patients exhibit structural abnormalities such as polymicrogyria (PMG) and periventricular nodular heterotopia (PNH) that are known to cause seizures and to be associated with 22q11DS. In this study we used a dedicated seizure imaging protocol to look for additional structural abnormalities in these individuals that may explain the elevated risk of seizure disorder in this patient group. METHODS: Nineteen consecutive adult subjects with 22q11DS underwent a 3 Tesla MRI with a dedicated high-resolution seizure protocol. Neurological exam was performed in all patients. Genome-wide analysis excluded the presence of other pathogenic microdeletions or duplications. RESULTS: Structural abnormalities were found in 11 of 14 subjects with sufficient image quality. These included three patients with PNH, one of whom had associated PMG. In addition, there was a surprisingly high prevalence of unilateral hippocampal malrotation (HIMAL), observed in 9 of 14 cases (64%). EEG findings showed interictal epileptiform discharges with focal distribution in four patients and generalized discharges in one patient. CONCLUSION: The results suggest that, in addition to other known structural abnormalities, 22q11DS is associated with HIMAL. It has been suggested that this developmental abnormality of the hippocampus may predispose or otherwise contribute to epileptogenesis. However in this study we observed HIMAL in a large proportion of patients, with and without epilepsy. Therefore, other as yet unknown factors may contribute to the high prevalence of epilepsy in this population.
BACKGROUND:Patients with chromosome 22q11.2 deletion syndrome (22q11DS) are at a seven fold increased risk of developing seizures. However, only a fraction of these patients exhibit structural abnormalities such as polymicrogyria (PMG) and periventricular nodular heterotopia (PNH) that are known to cause seizures and to be associated with 22q11DS. In this study we used a dedicated seizure imaging protocol to look for additional structural abnormalities in these individuals that may explain the elevated risk of seizure disorder in this patient group. METHODS: Nineteen consecutive adult subjects with 22q11DS underwent a 3 Tesla MRI with a dedicated high-resolution seizure protocol. Neurological exam was performed in all patients. Genome-wide analysis excluded the presence of other pathogenic microdeletions or duplications. RESULTS:Structural abnormalities were found in 11 of 14 subjects with sufficient image quality. These included three patients with PNH, one of whom had associated PMG. In addition, there was a surprisingly high prevalence of unilateral hippocampal malrotation (HIMAL), observed in 9 of 14 cases (64%). EEG findings showed interictal epileptiform discharges with focal distribution in four patients and generalized discharges in one patient. CONCLUSION: The results suggest that, in addition to other known structural abnormalities, 22q11DS is associated with HIMAL. It has been suggested that this developmental abnormality of the hippocampus may predispose or otherwise contribute to epileptogenesis. However in this study we observed HIMAL in a large proportion of patients, with and without epilepsy. Therefore, other as yet unknown factors may contribute to the high prevalence of epilepsy in this population.
Authors: Thomas M Maynard; Deepak Gopalakrishna; Daniel W Meechan; Elizabeth M Paronett; Jason M Newbern; Anthony-Samuel LaMantia Journal: Hum Mol Genet Date: 2012-10-16 Impact factor: 6.150
Authors: D A Driscoll; J Salvin; B Sellinger; M L Budarf; D M McDonald-McGinn; E H Zackai; B S Emanuel Journal: J Med Genet Date: 1993-10 Impact factor: 6.318
Authors: M A Montenegro; D Kinay; F Cendes; A Bernasconi; N Bernasconi; A C Coan; L M Li; M M Guerreiro; C A M Guerreiro; I Lopes-Cendes; E Andermann; F Dubeau; F Andermann Journal: J Neurol Neurosurg Psychiatry Date: 2006-03 Impact factor: 10.154
Authors: Stephen Chan; Jacqueline A Bello; Shlomo Shinnar; Dale C Hesdorffer; Darrell V Lewis; James MacFall; Ruth C Shinnar; William Gomes; Claire Litherland; Yuan Xu; Douglas R Nordli; John M Pellock; L Matthew Frank; Solomon L Moshé; Shumei Sun Journal: AJR Am J Roentgenol Date: 2015-11 Impact factor: 3.959
Authors: Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186
Authors: Wai Lun Alan Fung; Nancy J Butcher; Gregory Costain; Danielle M Andrade; Erik Boot; Eva W C Chow; Brian Chung; Cheryl Cytrynbaum; Hanna Faghfoury; Leona Fishman; Sixto García-Miñaúr; Susan George; Anthony E Lang; Gabriela Repetto; Andrea Shugar; Candice Silversides; Ann Swillen; Therese van Amelsvoort; Donna M McDonald-McGinn; Anne S Bassett Journal: Genet Med Date: 2015-01-08 Impact factor: 8.822
Authors: Maxwell J Roeske; Maureen McHugo; Simon Vandekar; Jennifer Urbano Blackford; Neil D Woodward; Stephan Heckers Journal: Mol Psychiatry Date: 2021-01-12 Impact factor: 13.437
Authors: Daniele Merico; Mehdi Zarrei; Gregory Costain; Lucas Ogura; Babak Alipanahi; Matthew J Gazzellone; Nancy J Butcher; Bhooma Thiruvahindrapuram; Thomas Nalpathamkalam; Eva W C Chow; Danielle M Andrade; Brendan J Frey; Christian R Marshall; Stephen W Scherer; Anne S Bassett Journal: G3 (Bethesda) Date: 2015-09-16 Impact factor: 3.154